AI chatbots direct users to private clinic stem cell claims

Artificial intelligence chatbots are directing users toward potentially misleading health advice from private medical providers, Medical Xpress reported. A study led by Simon Fraser University and published in BMJ Connections Digital Health & AI evaluated six popular chatbots, including ChatGPT and Claude. Researchers asked the systems questions about stem cell treatments for Alzheimer's disease, autism, and cerebral palsy. [1]

According to Medical Xpress, the chatbots frequently referred users to private clinics offering stem cell therapies despite a lack of strong clinical evidence for these conditions. Researchers noted that the AI models often failed to highlight the experimental nature of these interventions, raising concerns about patient safety and financial exploitation. [1]

The findings emphasize the growing reliance of the public on digital tools for medical guidance. The study authors cautioned that unverified promotional content from private providers can easily undermine evidence-based health communication when integrated into automated search results and conversational AI models. [1]